HIF 서적
이 책은 신약의 개발 및 유통에 관한 기존 규정을 보완하고, HIF 가 실현가능하며,글로벌 공공 보건 및 경제적 생산성에 있어서 작은 비용으로 큰 이득을 가져올 수 있음을 보여줍니다.
이번 판은 2008년에 집필되었습니다. 상당 부분이 개정, 확장 및 업데이트된 버전은 현재 준비 중입니다.
여기를 클릭하여 다운로드 하십시오간행물
- Aidan HollisThe Health Impact Fund and Price Determination
- Talha SyedShould a Prize System for Pharmaceuticals Require Patent Protection
- Thomas J. BollykyThe Relationship of the Health Impact Fund and Its Registrants
- Kalipso ChalkidouAssessing the Added Value of Health Technologies: NICE’s Experience
- Juggs Ravalia and Lennart SternThe MHIF System: Supporting the Health Impact Fund with Mobile
- Rudolf V. Van PuymbroeckThe Health Impact Fund: Creation and Commitment.
- Peter Singer and Doris Schroeder, lead authorsEthical Reasons for Intellectual Property Rights Reform: A Report
- Joy Mendel and Aidan HollisThe Health Impact Fund and Traditional Medicines.
- Aidan Hollis and Thomas PoggeProduct-Development Partnerships and the Health Impact Fund.
- Aidan Hollis and Thomas PoggeONU: groupe de haut niveau sur l'accès aux traitements médicaux
- Ishaan Nerurkar & Colton JangThe Health Impact Fund: A Mechanism Design Approach.
- Thomas Pogge & Aidan HollisSecretary-General's High-Level Panel on Access to Medicines
- Thomas Pogge & Aidan HollisResponse to the High-Level Panel and Expert Advisory Group
비디오
Health Impact Fund: Making New Medicines available to everyone
Reimagining pharmaceutical innovation | Thomas Pogge at TEDxCanberra
Is a Health Impact Fund an Equitable Solution to Fund Vaccine Access for All?
더 많은 비디오가 곧 게시 될 예정입니다.